Publications

Division/Center

Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018

JAMA Intern Med
Fu M, Naci H, Booth CM, Gyawali B, Cosgrove A, Toh S, Xu Z, Guan X, Ross-Degnan D, Wagner AK

Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval

JAMA Intern Med
Shahzad M, Naci H, Wagner AK.

Childhood Cancer Drugs in China: An Overview and Comparison of Regulatory Approvals in China and the United States.

Int J Cancer
Zhang Y, Wagner AK, Du H, Han T, Gupta S, Denburg AE, Frazier AL, Guan X, Shi L

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs.

JAMA Intern Med
Naci H, Guan X, Woloshin S, Xu Z, Wagner AK

Pharmacogenetic Polygenic Risk Score for Bronchodilator Response in Children and Adolescents with Asthma: Proof-of-Concept.

J Pers Med
Sordillo JE, Lutz SM, McGeachie MJ, Lasky-Su J, Weiss ST, Celedón JC, Wu AC

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending.

Cancer Commun (Lond)
Huang T, Wagner AK, Bai L, Huang C, Guan X, Shi L

What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool

BMJ Open
Sruamsiri R, Ferrario A, Ross-Degnan D, Denburg AE, Frazier AL, Gupta S, Ward ZJ, Yeh JM, Wagner AK

The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts.

J Law Med Ethics
Leopold C, Haffajee RL, Lu CY, Wagner AK

Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016.

Cancer
Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK

Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation: A Comparative Modeling Study.

Ann. Intern. Med.
Yeh JM, Lowry KP, Schechter CB, Diller LR, Alagoz O, Armstrong GT, Hampton JM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Oeffinger KC, Trentham-Dietz A, Stout NK

Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand

Bull World Health Organ
Ferrario A, Stephens P, Guan X, Ross-Degnan D, Wagner A

Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process.

Cancer
Perni S, Milligan MG, Saraf A, Vivenzio T, Marques A, Baker MA, Kosak T, Bartlett S, Physic MA, Batchelder MR, McBride S, Bredfeldt J, Cail DW, Kearney MC, Whitehouse C, Orio P, Walsh G, Haas-Kogan DA, Martin NE

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study.

BMJ Open
Hsu JC, Wei CF, Yang SC, Lin PC, Lee YC, Lu CY

Embedding mobile health technology into the Nurses' Health Study 3 to study behavioral risk factors for cancer.

Cancer Epidemiol. Biomarkers Prev.
Fore R, Hart JE, Choirat C, Thompson JW, Lynch K, Laden F, Chavarro JE, James P

Commentary: Creating a patient-centered decision aid for ductal carcinoma in situ.

Breast J
Ozanne EM, Soeteman DI, Frank ES, Clarke J, Hassett MJ, Stout NK, Punglia RS

Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials

Clin Pharmacol Ther
Carrigan G, Whipple S, Capra WB, Taylor MD, Brown JS, Lu M, Arnieri B, Copping R, Rothman KJ

Differences in reimbursement listing of anticancer therapies in China: an observational study.

BMJ Open
Guan X, Zhang Y, Wushouer H, Shi L, Ross-Degnan D, Wagner AK

Improvements in Sepsis-Associated Mortality in Hospitalized Cancer vs Non-Cancer Patients: A 12-Year Analysis Using Clinical Data.

Ann Am Thorac Soc
Cooper AJ, Keller S, Chan C, Glotzbecker BE, Klompas M, Baron RM, Rhee C,

Immunity to commensal papillomaviruses protects against skin cancer.

Nature
Strickley JD, Messerschmidt JL, Awad ME, Li T, Hasegawa T, Ha DT, Nabeta HW, Bevins PA, Ngo KH, Asgari MM, Nazarian RM, Neel VA, Jenson AB, Joh J, Demehri S

Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML

J Natl Compr Canc Netw
Banegas MP, Rivera DR, O'Keeffe-Rosetti MC, Carroll NM, Pawloski PA, Tabano DC, Epstein MM, Yeung K, Hornbrook MC, Lu C, Ritzwoller DP